Skip to main content

SPONSORSHIP | Become a sponsor today!

Scripps Research Lecture: ‘Intervention Into Multiple Sclerosis With Next-Generation Therapies'


  • WHEN Wednesday, July 1, 2020 at 4 p.m.
  • WHERE Virtual
  • AGES All ages
  • COST Free

Intelligent Intervention Into Multiple Sclerosis With Next-Generation Therapies - Front Row Lecture with Hugh Rosen, MD, PhD & Luke Lairson, PhD

As scientists learn more about the underlying causes of multiple sclerosis (MS), they are developing intelligent interventions that slow or halt the progression of the disease. In this Front Row lecture, Scripps Research Professor Hugh Rosen will share how he and his collaborators at Scripps Research created ozanimod (Zeposia), the first disease-altering MS therapy, recently approved in the United States and Europe. Luke Lairson, an associate professor at Scripps Research, will discuss how his research targeting another aspect of the disease is laying the groundwork for the next generation of MS therapies.


For more information, visit:

Dates and times of events are subject to change without notice. Always check the event organizer's website for the most updated schedule before attending.

SPONSORSHIP | Become a sponsor today!